N–Methyl–D–aspartate antagonists limit aminoglycoside antibiotic–induced hearing loss

Authors:
  • JHJer-Min Huang
    Jer-Min Huang
  • CXChen Xie
    Chen Xie
  • DWDouglas Webster
    Douglas Webster
  • CBCharles Berlin
    Charles Berlin
  • PSPhil Skolnick
    Phil Skolnick

Abstract
The use of aminoglycoside antibiotics is limited by ototoxicity that can produce permanent hearing loss. We report that concurrent administration of N-methyl-D-aspartate (NMDA) antagonists markedly attenuates both the hearing loss and destruction of cochlear hair cells in guinea pigs treated with aminoglycoside antibiotics. These findings indicate that aminoglycoside-induced hearing loss is mediated, in part, through an excitotoxic process. The high correlation (Spearman correlation coefficient: 0.928; P < 0.01) obtained between the relative cochleotoxicities of a series of aminoglycosides in humans and the potencies of these compounds to produce a polyamine-like enhancement of [3H]dizocilpine binding to NMDA receptors is consistent with this hypothesis, and provides a simple in vitro assay that can predict this aspect of aminoglycoside-induced ototoxicity.

This publication has 29 references indexed in Scilit: